The pre-filled syringe (PFS) market is growing rapidly, driven by the rising need for innovative biologics and a desire for self-administration treatment options offering greater convenience. This increased demand for PFS is fuelling innovation in mainstream packaging design to support advancements aiding both useability and patient safety.
However, supporting the PFS packaging needs of the expanding biologics market comes with many challenges. These include carefully selecting the right packaging solutions for each project and potentially committing considerable capital expenditure to upgrade manufacturing lines. As a result, adopting new PFS packaging and harnessing new technologies could be a daunting task, particularly for smaller biologics developers.